InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Kulkarni Samarth, Chairman & CEO. Insider active across 1 companies, notably CRISPR Therapeutics AG. In total, 18 disclosures have been logged. The latest transaction was disclosed on 29 June 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations18 total
€300,81625,000 shares@ €12.03260.0064% mcap19.6% of flow
Common Shares
SEC:0001209191-22-040343:0·
11,834 shares
Common Shares
SEC:0001209191-22-018613:0·
€28,57417,750 shares@ €1.60984.6% of flow
Common Shares
SEC:0001209191-21-070994·
€28,57417,750 shares@ €1.60980.0006% mcap1.9% of flow
Common Shares
SEC:0001209191-21-070994:0·
80,000 shares
Common Shares
SEC:0001209191-21-068456·
80,000 shares
Common Shares
SEC:0001209191-21-068456:0·
€51,634779 shares@ €66.28258.4% of flow
Common Shares
SEC:0001209191-21-068013·
€51,634779 shares@ €66.28250.0011% mcap3.4% of flow
Common Shares
SEC:0001209191-21-068013:0·
€51,52933,000 shares@ €1.56158.4% of flow
Common Shares
SEC:0001209191-21-060775·
€51,52933,000 shares@ €1.56150.0011% mcap3.4% of flow
Common Shares
SEC:0001209191-21-060775:0·
€82,968787 shares@ €105.422713.5% of flow
Common Shares
SEC:0001209191-21-054903·
€82,968787 shares@ €105.42270.0018% mcap5.4% of flow
Common Shares
SEC:0001209191-21-054903:0·
€15,9281,500 shares@ €10.61892.6% of flow
Common Shares
SEC:0001209191-21-050256·
€15,9281,500 shares@ €10.61890.0003% mcap1.0% of flow
Common Shares
SEC:0001209191-21-050256:0·
€310,95730,000 shares@ €10.365250.5% of flow
Common Shares
SEC:0001209191-21-041602·
€310,95730,000 shares@ €10.36520.0067% mcap20.3% of flow
Common Shares
SEC:0001209191-21-041602:0·
€73,834779 shares@ €94.7812.0% of flow
Common Shares
SEC:0001209191-21-037801·
€73,834779 shares@ €94.780.0016% mcap4.8% of flow
Common Shares
SEC:0001209191-21-037801:0·
18 of 18 declarations
About Kulkarni Samarth
Samarth Kulkarni is an executive at CRISPR Therapeutics AG.
